Make your mark at the world’s largest MS research meeting by sharing your work with leading experts in the field of neurology.
All accepted regular and late breaking abstracts for ECTRIMS 2024 have been published in the online supplement of the Multiple Sclerosis Journal and on our website, mobile app & platform. Authors selected from a diverse range of research topics related to multiple sclerosis and related neurological disorders, which are categorised into four primary areas: Clinical Aspects of MS, Pathology and Pathogenesis of MS, Imaging and Non-Imaging Biomarkers, and Therapy.
Brit Ellen Rød
Norway
Cladribine vs Rituximab in Relapsing-Remitting Multiple Sclerosis: A Parallel Cohort Study on Comparative Long-Term Effectiveness
Giacomo Boffa
Italy
Determinants driving evolution of newly formed MS lesion into chronic active, chronic demyelinated and remyelinated lesions
Paolo Preziosa
Italy
P675 | In-Vivo Assessment of Cellular Soma and Neurite Density Abnormalities in Multiple Sclerosis Paramagnetic Rim and Core-Sign Lesions
Colm Elliott
Canada
P677 | MS Perilesional White Matter Abnormalities detected on MRI may largely represent Residual Damage from the Acute Stage of Lesion Formation
Ruth Dobson
United Kingdom
P085 | Pregnancy and infant outcomes in women with multiple sclerosis receiving ocrelizumab: Analysis of approximately 4,000 pregnancies to date
Antonino Giordano
Italy
P128 | Genetic-driven impairment of mitochondrial function in primary progressive multiple sclerosis
Eva Krijnen
USA
P177 | Evolution of cortical lesions and domain-specific cognitive decline in multiple sclerosis
